Probiotic may reduce GI risk in children with cow’s milk allergy

  • J Pediatr
  • 18 Jul 2019

  • International Clinical Digest
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • Children with cow’s milk allergy (CMA) as infants may have reduced risk for functional gastrointestinal disorders (FGIDs) later in life if treated with a combination of extensively hydrolysed casein formula (EHCF) and the probiotic Lactobacillus rhamnosus GG (LGG).
  • Researchers report reduced functional dyspepsia, constipation, and abdominal pain.

Why this matters

  • This simple dietary intervention, if validated in larger trials, could present a possible low-cost preventative for later, potentially chronic gastrointestinal conditions.

Study design

  • Researchers examined children with a history of CMA during the first year of life who subsequently outgrew it ≥12 months before the study period (n=220 plus 110 consecutive healthy controls).
  • They treated patients with either EHCF alone or in combination with LGG.
  • Funding: Italian Ministry of Health; Mead Johnson Nutrition.

Key results

  • EHCF+LGG group developed ≥1 FGID at a significantly lower rate than the EHCF group (40% vs 16.4%; P<.05>
  • The FGID incidence rate ratio for the EHCF+LGG group vs the EHCF group was unchanged after correcting for age at CMA diagnosis, breastfeeding, weaning time, and first-degree relatives with 1 or more FGIDs (0.40; 95% CI, 0.25-0.65; P<.001>

Limitations

  • The study was single-centre, not randomised, and did not assess long-term treatment effects.
  • Results may not apply to children with other food allergies or health conditions.